GENE ONLINE|News &
Opinion
Blog

NDA
Trials & Approvals FDA
Otsuka and Lundbeck’s Treatment for Schizophrenia and Bipolar I NDA Accepted by the FDA
2022-09-13
In-Depth Hearing Loss
Fennec Submits Hearing Loss Drug for Third Time After Prior FDA Approval Rejections
2022-04-28
Trials & Approvals Depression
Biogen, Sage Pursue 2022 Filing for Depression Therapy, Zuranolone
2021-10-20
NDA
Daiichi Sankyo Files NDA for a New Oncolytic Virus in Japan
2021-01-07
Liver Cancer
China’s Regulatory Body Accepts Application for First Selective Internal Radiation Therapy for HCC
2020-11-29
Ranking & Reports
Weekly Top 5 in China (0127-0202)
2019-01-29
Trials & Approvals Anti-PD-1
Innovent reports clinical trial results of its anti-PD-1 monoclonal antibody
2018-09-26
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top